Fever in the Returned Traveler
Clinical Pathways promote evidence-based, safe, and high-value patient care by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by a methodical review of available evidence and consensus among committee members.
Clinical Pathway:
- Fever in the Returned Traveler Algorithm
- Fever in the Returned Traveler Synopsis – provides care standards employed for this clinical pathway)
Inclusion and exclusion criteria:
- Inclusion:
- Patients presenting with fever and concern for travel-related illness
- Exclusion:
- Patients with concern for measles
- Patients with concern for tuberculosis infection
- Patients with concern for viral special pathogen infection (e.g., Ebola virus)
Committee members involved in the development:
- Anik Patel, MD, FAAP | Emergency Department | Committee Chair
- Chris Day, MD | Infectious Diseases | Committee Member
- James Hubbard, MD | Urgent Care | Committee Member
- Erin McCann, MD, MPH | General Academic Pediatrics | Committee Member
EBP Committee Members:
- Todd Glenski, MD, MSHA, FASA | Anesthesiology, Evidence Based Practice
- Megan Gripka, MPH, MLS (ASCP) SM | Evidence Based Practice
Publication dates:
- Finalized date: 10/2025
- Next expected revision date: 2028
Concerns with content:
If you have any questions regarding this content or identify a broken link, please email evidencebasedpractice@cmh.edu.
These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.